# Skytrofa

NDC: 73362-005
Generic name: Lonapegsomatropin-tcgd
Labeler / Manufacturer: Ascendis Pharma Endocrinology, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20210825

FDA application: BLA761177

## Active ingredients

- LONAPEGSOMATROPIN: 4.3 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73362-005"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73362-005
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9229f871-bc61-4ddc-8122-d126d40e36ac